TSX Delisting Review - Acerus Pharmaceuticals Corporation (ASP, ASP.WT)
March 9, 2020
| Issuer: | Acerus Pharmaceuticals Corporation (the "Company") |
| Securities: | Common shares Common share purchase warrants |
| Symbol(s): | ASP ASP.WT |
| Delisting Review Status: | TSX has determined that the Company has regained compliance with the requirements for continued listing. |
| Additional Information: | Please refer to TSX Bulletin #2020-0101 dated February 13, 2020. |
| TSX contact: | Chris Birkett, Director, Toronto Stock Exchange. |